PortfoliosLab logoPortfoliosLab logo
SNY vs. UNH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SNY vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sanofi (SNY) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SNY achieves a -6.78% return, which is significantly lower than UNH's 15.37% return. Over the past 10 years, SNY has underperformed UNH with an annualized return of 4.63%, while UNH has yielded a comparatively higher 12.52% annualized return.


SNY

1D
-0.37%
1M
-1.96%
YTD
-6.78%
6M
-9.38%
1Y
-8.16%
3Y*
-1.21%
5Y*
0.44%
10Y*
4.63%

UNH

1D
-0.51%
1M
2.48%
YTD
15.37%
6M
18.14%
1Y
27.52%
3Y*
-7.07%
5Y*
0.18%
10Y*
12.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SNY vs. UNH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SNY
Sanofi
-6.78%4.93%1.09%6.55%0.57%7.00%0.39%20.47%6.06%9.96%
UNH
UnitedHealth Group Incorporated
15.37%-33.14%-2.41%0.80%6.94%45.20%21.25%20.00%14.52%39.83%

Correlation

The correlation between SNY and UNH is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2002

0.30

The correlation between SNY and UNH shifts across timeframes, from 0.13 (1 year) to 0.30 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SNY:

$103.08B

UNH:

$343.91B

EPS

SNY:

$3.09

UNH:

$13.23

PE Ratio

SNY:

13.86

UNH:

28.57

PS Ratio

SNY:

2.21

UNH:

0.77

PB Ratio

SNY:

1.42

UNH:

3.31

Total Revenue (TTM)

SNY:

$47.35B

UNH:

$449.71B

Gross Profit (TTM)

SNY:

$34.18B

UNH:

$84.55B

EBITDA (TTM)

SNY:

$12.63B

UNH:

$22.99B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SNY vs. UNH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNY
SNY Risk / Return Rank: 2323
Overall Rank
SNY Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
SNY Sortino Ratio Rank: 2424
Sortino Ratio Rank
SNY Omega Ratio Rank: 2323
Omega Ratio Rank
SNY Calmar Ratio Rank: 2323
Calmar Ratio Rank
SNY Martin Ratio Rank: 1919
Martin Ratio Rank

UNH
UNH Risk / Return Rank: 6060
Overall Rank
UNH Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
UNH Sortino Ratio Rank: 5757
Sortino Ratio Rank
UNH Omega Ratio Rank: 6060
Omega Ratio Rank
UNH Calmar Ratio Rank: 6161
Calmar Ratio Rank
UNH Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SNY vs. UNH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SNYUNHDifference

Sharpe ratio

Return per unit of total volatility

-0.33

0.69

-1.02

Sortino ratio

Return per unit of downside risk

-0.28

1.14

-1.42

Omega ratio

Gain probability vs. loss probability

0.96

1.17

-0.21

Calmar ratio

Return relative to maximum drawdown

-0.51

0.99

-1.50

Martin ratio

Return relative to average drawdown

-1.01

2.18

-3.19

SNY vs. UNH - Sharpe Ratio Comparison

The current SNY Sharpe Ratio is -0.33, which is lower than the UNH Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of SNY and UNH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SNYUNHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.33

0.69

-1.02

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.02

0.01

+0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.20

0.42

-0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

0.20

0.63

-0.43

Drawdowns

SNY vs. UNH - Drawdown Comparison

The maximum SNY drawdown since its inception was -46.46%, smaller than the maximum UNH drawdown of -74.37%. Use the drawdown chart below to compare losses from any high point for SNY and UNH.


Loading charts...

Drawdown Indicators


SNYUNHDifference

Max Drawdown

Largest peak-to-trough decline

-46.46%

-74.37%

+27.91%

Max Drawdown (1Y)

Largest decline over 1 year

-16.70%

-28.96%

+12.26%

Max Drawdown (3Y)

Largest decline over 3 years

-23.37%

-61.39%

+38.02%

Max Drawdown (5Y)

Largest decline over 5 years

-33.52%

-61.39%

+27.87%

Max Drawdown (10Y)

Largest decline over 10 years

-33.52%

-61.39%

+27.87%

Current Drawdown

Current decline from peak

-20.60%

-37.35%

+16.75%

Average Drawdown

Average peak-to-trough decline

-12.19%

-14.76%

+2.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.39%

13.18%

-4.79%

Volatility

SNY vs. UNH - Volatility Comparison

The current volatility for Sanofi (SNY) is 5.39%, while UnitedHealth Group Incorporated (UNH) has a volatility of 6.91%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SNYUNHDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.39%

6.91%

-1.52%

Volatility (6M)

Calculated over the trailing 6-month period

14.94%

30.89%

-15.95%

Volatility (1Y)

Calculated over the trailing 1-year period

24.93%

39.87%

-14.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.68%

31.78%

-7.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.42%

30.15%

-6.73%

Dividends

SNY vs. UNH - Dividend Comparison

SNY's dividend yield for the trailing twelve months is around 5.66%, more than UNH's 2.34% yield.


PositionTTM20252024202320222021202020192018201720162015
SNY
Sanofi
5.66%4.56%4.22%3.83%4.32%3.80%3.61%3.47%4.29%3.82%4.11%3.77%
UNH
UnitedHealth Group Incorporated
2.34%2.64%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%

Financials

SNY vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between Sanofi and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B120.00B20222023202420252026
11.24B
111.72B
(SNY) Total Revenue
(UNH) Total Revenue
Values in USD except per share items

SNY vs. UNH - Profitability Comparison

The chart below illustrates the profitability comparison between Sanofi and UnitedHealth Group Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
72.1%
22.7%
Portfolio components
SNY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanofi reported a gross profit of 8.11B and revenue of 11.24B. Therefore, the gross margin over that period was 72.1%.

UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, UnitedHealth Group Incorporated reported a gross profit of 25.41B and revenue of 111.72B. Therefore, the gross margin over that period was 22.7%.

SNY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanofi reported an operating income of 2.27B and revenue of 11.24B, resulting in an operating margin of 20.2%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, UnitedHealth Group Incorporated reported an operating income of 8.99B and revenue of 111.72B, resulting in an operating margin of 8.1%.

SNY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanofi reported a net income of 1.61B and revenue of 11.24B, resulting in a net margin of 14.4%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, UnitedHealth Group Incorporated reported a net income of 6.28B and revenue of 111.72B, resulting in a net margin of 5.6%.


Frequently Asked Questions


SNY and UNH have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

UNH has higher volatility (6.91%) compared to SNY (5.39%). In terms of maximum drawdown, SNY dropped -46.46% vs UNH's -74.37%.

UNH currently has the higher Sharpe Ratio (0.69 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SNY and UNH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer